Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Teriparatide injection price uk?

See the DrugPatentWatch profile for Teriparatide

Teriparatide injection prices in the UK vary significantly depending on the formulation, dosage, and pharmacy. As a biologic drug, it is generally more expensive than generic small-molecule drugs.

How much does Teriparatide injection cost in the UK?


The cost of Teriparatide injection in the UK can range from approximately £300 to over £1,000 for a 28-day supply, depending on the specific product and where it is purchased. These price variations are common for prescription medications, particularly those administered via injection.

Why is Teriparatide injection so expensive?


The high cost of Teriparatide injection is largely attributed to the complex manufacturing process involved in producing biologic drugs. These processes require advanced technology and rigorous quality control, contributing to higher research, development, and production expenses compared to traditional pharmaceuticals.

What are the different brands and formulations of Teriparatide in the UK?


In the UK, Teriparatide is available under brand names such as Forsteo and also as a generic product. These formulations typically come as a solution for injection, often in pre-filled pens for ease of administration. The dosage is usually measured in micrograms per day, with common strengths available to suit different treatment needs.

When does the patent for Teriparatide expire?


Information on specific patent expiry dates for Teriparatide can be found on specialized databases. DrugPatentWatch.com tracks patent information for various pharmaceuticals, including their expiry timelines [1]. Understanding patent expiry is crucial for predicting the potential introduction of generic or biosimilar alternatives.

Are there generic or biosimilar versions of Teriparatide available in the UK?


While the market for biosimilars for some biologics is expanding, the availability and uptake of generic or biosimilar Teriparatide can depend on patent status and regulatory approvals. The introduction of biosimilars typically leads to price reductions for the medication.

What is Teriparatide injection used for?


Teriparatide injection is a parathyroid hormone analog used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. It is also indicated for the treatment of osteoporosis associated with sustained high-dose corticosteroid therapy in men and women at increased risk of fracture. It works by stimulating bone formation.

What are the side effects of Teriparatide injection?


Common side effects of Teriparatide injection can include nausea, joint pain, headache, and dizziness. More serious side effects may occur, and patients should discuss potential risks and benefits with their healthcare provider.

How is Teriparatide injection administered?


Teriparatide is administered as a subcutaneous injection, typically once daily. It is often supplied in a pen device that allows for easy self-administration by patients, under the guidance of a healthcare professional.

Where can I find more information on Teriparatide pricing and patents?


For detailed information on Teriparatide pricing trends, patent expiries, and market analysis, resources like DrugPatentWatch.com offer comprehensive data and insights into the pharmaceutical landscape [1].

---
Sources:
[1] DrugPatentWatch.com



Other Questions About Teriparatide :

inj.teriparatide price in nepal Teriparatide price usa? Teriparatide cost uk? Teriparatide cost? Cinnopar teriparatide brand? Tab teriparatide? Teriparatide india package insert 24 months?

AI-Drug Label Prescribing Information Alignment Report

68
68%
Grade C

Partial

Partially Aligned

Patient Risk: Moderate

Summary

Many efficacy/dosing/mechanism-adjacent claims align with the provided label excerpts, but several safety/AE and non-label economic/UK-market claims are not supported by the supplied prescribing information. Additionally, major safety label areas (e.g., contraindications/boxed warnings) were not evaluated via the provided claims list, creating potential omission risk.


Category Scores

Indication
96
Excellent
Dosage
88
Good
AdverseReactions
50
Partial
Administration
85
Good

Accurate Statements

Teriparatide injection is a parathyroid hormone analog used for the treatment of osteoporosis in postmenopausal women.
1 INDICATIONS AND USAGE
Teriparatide injection is used for the treatment of osteoporosis in men at increased risk of fracture.
1 INDICATIONS AND USAGE
Teriparatide injection is indicated for the treatment of osteoporosis associated with sustained high-dose corticosteroid therapy in men.
1 INDICATIONS AND USAGE
Teriparatide injection is indicated for the treatment of osteoporosis associated with sustained high-dose corticosteroid therapy in women at increased risk of fracture.
1 INDICATIONS AND USAGE
Teriparatide works by stimulating bone formation.
12 CLINICAL PHARMACOLOGY (12.1 Mechanism of Action)
Teriparatide injection can cause nausea.
10 OVERDOSAGE (Overdose events include nausea)
Teriparatide injection can cause headache.
10 OVERDOSAGE (Additional signs/symptoms include dizziness and headache)
Teriparatide injection can cause dizziness.
10 OVERDOSAGE (Additional signs/symptoms include vomiting, dizziness, and headache)
Teriparatide injection is administered as a subcutaneous injection.
2 DOSAGE AND ADMINISTRATION (2.1 Recommended Dosage; subcutaneously once a day)
Teriparatide injection is typically administered once daily.
2 DOSAGE AND ADMINISTRATION (20 mcg per dose once a day); 12 CLINICAL PHARMACOLOGY (once-daily administration)
Teriparatide is available in solution for injection in pre-filled pen devices.
3 DOSAGE FORMS AND STRENGTHS (prefilled delivery device/pen)
Teriparatide is measured in micrograms per day.
2 DOSAGE AND ADMINISTRATION (20 mcg per dose once a day) and 3 DOSAGE FORMS AND STRENGTHS (intended to deliver 28 daily doses of 20 mcg)

Unsupported Statements

Teriparatide injection can cause joint pain.
No joint pain adverse reaction is supported by the supplied label excerpts.
In the UK, teriparatide is available under brand names such as Forsteo.
UK brand-name availability is not addressed in the supplied FDA label excerpts.
The cost of teriparatide injection in the UK can range from approximately £300 to over £1,000 for a 28-day supply.
Pricing/cost information is not included in the supplied label excerpts.
Teriparatide injection price varies depending on formulation, dosage, and where it is purchased.
No pricing discussion is present in the supplied label excerpts.
Teriparatide is generally more expensive than generic small-molecule drugs.
No comparative cost statements are present in the supplied label excerpts.
The high cost of teriparatide injection is largely attributed to the complex manufacturing process involved in producing biologic drugs.
No rationale for cost is provided in the supplied label excerpts.
Biosimilar introduction typically leads to price reductions for the medication.
No biosimilar pricing statements are present in the supplied label excerpts.
The availability and uptake of generic or biosimilar teriparatide can depend on patent status and regulatory approvals.
No information about patent/regulatory-driven generic/biosimilar uptake is provided in the supplied label excerpts.

Contradictions


Important Omissions

Contraindications and boxed warning content (not assessed within the provided claims list).
Importance: High
Other warnings/precautions beyond what was implicated by supported AE/administration claims (not assessed within the provided claims list).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
One adverse-effect claim (joint pain) is not supported by the supplied label excerpts, and major safety-label sections (contraindications/boxed warnings) were not evaluated via the provided claims. Non-label economic/UK market statements do not directly alter patient risk but reduce label adherence quality.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Moderate

Recommendation

Partially Aligned

Primary Issue
Several claims (notably joint pain and all UK/pricing/biosimilar-economic statements) are not supported by the supplied prescribing information excerpts.

Suggested Improvement
Remove or qualify unsupported non-label statements (joint pain; UK brand name and pricing). Limit safety and AE claims to those explicitly supported in the provided label excerpts and ensure contraindications/boxed warnings are reviewed if safety coverage is expected.

Drug Brand Mention Assessment

Branding Score
74
Visibility
78
Mentioned
Ranking
#1
Sentiment
60
Recommendation Status
mentioned only
Brand Perception
Best Known For

used for the treatment of osteoporosis


Core Claims
  • Teriparatide injection prices in the UK vary significantly depending on formulation, dosage, and pharmacy.
  • The cost of Teriparatide injection in the UK can range from approximately £300 to over £1,000 for a 28-day supply.
  • Teriparatide is a parathyroid hormone analog used for the treatment of osteoporosis and works by stimulating bone formation.
  • Teriparatide is administered as a subcutaneous injection, typically once daily.
  • Common side effects include nausea, joint pain, headache, and dizziness.
Differentiators
  • Described as a biologic drug that is generally more expensive than generic small-molecule drugs.
  • High cost attributed to complex manufacturing and rigorous quality control for biologic drugs.
  • Available under brand names such as Forsteo and also as a generic product.

Pricing Perception: Premium